Obesity and Cancer

4
【 This post was originally published on here. 】
  • Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309(1):71-82.

    [PubMed Abstract]

  • Kitahara CM, Flint AJ, Berrington de Gonzalez A, et al. Association between class III obesity (BMI of 40-59 kg/m2) and mortality: a pooled analysis of 20 prospective studies. PLoS Medicine 2014; 11(7):e1001673.

    [PubMed Abstract]

  • National Center for Health Statistics. Health, United States, 2015: With Special Feature on Racial and Ethnic Health Disparities. Hyattsville, MD. 2016.

  • Ogden CL, Carroll MD, Lawman HG, et al. Trends in obesity prevalence among children and adolescents in the United States, 1988-1994 through 2013-2014. JAMA 2016; 315(21):2292-2299.

    [PubMed Abstract]

  • Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014; 311(8):806-814.

    [PubMed Abstract]

  • Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body Fatness and Cancer–Viewpoint of the IARC Working Group. New England Journal of Medicine 2016; 375(8):794-798. doi: 10.1056/NEJMsr1606602.

  • Setiawan VW, Yang HP, Pike MC, et al. Type I and II endometrial cancers: have they different risk factors? Journal of Clinical Oncology 2013; 31(20):2607-2618.

    [PubMed Abstract]

  • Dougan MM, Hankinson SE, Vivo ID, et al. Prospective study of body size throughout the life-course and the incidence of endometrial cancer among premenopausal and postmenopausal women. International Journal of Cancer 2015; 137(3):625-37.

    [PubMed Abstract]

  • Hoyo C, Cook MB, Kamangar F, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. International Journal of Epidemiology 2012; 41(6):1706-1718.

    [PubMed Abstract]

  • Chen Y, Liu L, Wang X, et al. Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies. Cancer Epidemiology, Biomarkers & Prevention 2013; 22(8):1395-1408.

    [PubMed Abstract]

  • Chen Y, Wang X, Wang J, Yan Z, Luo J. Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. European Journal of Cancer 2012; 48(14):2137-2145.

    [PubMed Abstract]

  • Campbell PT, Newton CC, Freedman ND, et al. Body mass index, waist circumference, diabetes, and risk of liver cancer for U.S. adults. Cancer Research 2016; 76(20):6076-6083.

    [PubMed Abstract]

  • Wang F, Xu Y. Body mass index and risk of renal cell cancer: a dose-response meta-analysis of published cohort studies. International Journal of Cancer 2014; 135(7):1673-86.

    [PubMed Abstract]

  • Sanfilippo KM, McTigue KM, Fidler CJ, et al. Hypertension and obesity and the risk of kidney cancer in 2 large cohorts of US men and women. Hypertension 2014; 63(5):934-41.

    [PubMed Abstract]

  • Wallin A, Larsson SC. Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies. European Journal of Cancer 2011; 47(11):1606-1615.

    [PubMed Abstract]

  • Niedermaier T, Behrens G, Schmid D, et al. Body mass index, physical activity, and risk of adult meningioma and glioma: A meta-analysis. Neurology 2015; 85(15):1342-1350.

    [PubMed Abstract]

  • Genkinger JM, Spiegelman D, Anderson KE, et al. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. International Journal of Cancer 2011; 129(7):1708-1717.

    [PubMed Abstract]

  • Ma Y, Yang Y, Wang F, et al. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS One 2013; 8(1):e53916.

    [PubMed Abstract]

  • World Cancer Research Fund International/American Institute for Cancer Research. Continuous Update Project Report: Diet, Nutrition, Physical Activity and Gallbladder Cancer. 2015. Available at http://www.wcrf.org/sites/default/files/Gallbladder-Cancer-2015-Report.pdf.

  • Li L, Gan Y, Li W, Wu C, Lu Z. Overweight, obesity and the risk of gallbladder and extrahepatic bile duct cancers: A meta-analysis of observational studies. Obesity (Silver Spring) 2016; 24(8):1786-1802.

    [PubMed Abstract]

  • Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371(9612):569-578.

    [PubMed Abstract]

  • Munsell MF, Sprague BL, Berry DA, Chisholm G, Trentham-Dietz A. Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiologic Reviews 2014; 36:114-136.

    [PubMed Abstract]

  • Brinton LA, Cook MB, McCormack V, et al. Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. Journal of the National Cancer Institute 2014; 106(3):djt465.

    [PubMed Abstract]

  • Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Medicine 2012; 9(4):e1001200.

    [PubMed Abstract]

  • Kitahara CM, McCullough ML, Franceschi S, et al. Anthropometric factors and thyroid cancer risk by histological subtype: Pooled analysis of 22 prospective studies. Thyroid 2016; 26(2):306-318.

    [PubMed Abstract]

  • Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annual Review of Immunology 2011; 29:415-445.

    [PubMed Abstract]

  • Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. International Journal of Cancer 2006; 118(7):1591-1602.

    [PubMed Abstract]

  • Bishayee A. The role of inflammation and liver cancer. Advances in Experimental Medicine and Biology 2014; 816:401-435.

    [PubMed Abstract]

  • Gallagher EJ, LeRoith D. Obesity and diabetes: The increased risk of cancer and cancer-related mortality. Physiological Reviews 2015; 95(3):727-748.

    [PubMed Abstract]

  • Seo BR, Bhardwaj P, Choi S. Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis. Science Translational Medicine 2015; 7(301):301ra130.

    [PubMed Abstract]

  • Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: new perspectives. Annual Review of Medicine 2010; 61:301–316.

    [PubMed Abstract]

  • Arnold M, Pandeya N, Byrnes G, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncology 2015; 16(1):36-46.

    [PubMed Abstract]

  • Whiteman DC, Wilson LF. The fractions of cancer attributable to modifiable factors: A global review. Cancer Epidemiology 2016; 44:203-221.

    [PubMed Abstract]

  • Keum N, Greenwood DC, Lee DH, et al. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. Journal of the National Cancer Institute 2015; 107(2). pii: djv088.

    [PubMed Abstract]

  • Tee MC, Cao Y, Warnock GL, Hu FB, Chavarro JE. Effect of bariatric surgery on oncologic outcomes: a systematic review and meta-analysis. Surgical Endoscopy 2013; 27(12):4449-4456.

    [PubMed Abstract]

  • Neuhouser ML, Aragaki AK, Prentice RL, et al. Overweight, obesity, and postmenopausal invasive breast cancer risk: A secondary analysis of the Women’s Health Initiative randomized clinical trials. JAMA Oncology 2015; 1(5):611-621.

    [PubMed Abstract]

  • Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. New England Journal of Medicine 2003; 348(17):1625-1638.

    [PubMed Abstract]

  • Schmitz KH, Neuhouser ML, Agurs-Collins T, et al. Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. Journal of the National Cancer Institute 2013; 105(18):1344-1354.

    [PubMed Abstract]

  • Paskett ED, Dean JA, Oliveri JM, Harrop JP. Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review. Journal of Clinical Oncology 2012; 30(30):3726-3733.

    [PubMed Abstract]

  • Gacci M, Sebastianelli A, Salvi M, et al. Role of abdominal obesity for functional outcomes and complications in men treated with radical prostatectomy for prostate cancer: results of the Multicenter Italian Report on Radical Prostatectomy (MIRROR) study. Scandinavian Journal of Urology 2014; 48(2):138-145.

    [PubMed Abstract]

  • Meyerhardt JA, Tepper JE, Niedzwiecki D, et al. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. Journal of Clinical Oncology 2004; 22(4):648-657.

    [PubMed Abstract]

  • Teras LR, Kitahara CM, Birmann BM, et al. Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies. British Journal of Haematology 2014; 166(5):667-676.

    [PubMed Abstract]

  • Goodwin PJ, Segal RJ, Vallis M, et al. Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial. Journal of Clinical Oncology 2014; 32(21):2231-2239.

    [PubMed Abstract]

  • Harrigan M, Cartmel B, Loftfield E, et al. Randomized trial comparing telephone versus in-person weight loss counseling on body composition and circulating biomarkers in women treated for breast cancer: The Lifestyle, Exercise, and Nutrition (LEAN) Study. Journal of Clinical Oncology 2016; 34(7):669-676.

    [PubMed Abstract]

  • Goodwin PJ. Obesity and breast cancer outcomes: How much evidence is needed to change practice? Journal of Clinical Oncology 2016; 34(7):646-648. Epub 2015 Dec 28. doi: 10.1200/JCO.2015.64.7503.

  • Sheflin AM, Whitney AK, Weir TL. Cancer-promoting effects of microbial dysbiosis. Current Oncology Reports 2014; 16(10):406.

    [PubMed Abstract]

  • Sivan A, Corrales L, Hubert N, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 2015; 350(6264):1084-1089.

    [PubMed Abstract]

  • Vétizou M, Pitt JM, Daillère R, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 2015; 350(6264):1079-1084.

    [PubMed Abstract]

  • Barrington WE, Schenk JM, Etzioni R, et al. Difference in association of obesity with prostate cancer risk between US African American and non-Hispanic white men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA Oncology 2015; 1(3):342-349.

    [PubMed Abstract]